Stilla Technologies commercializes a revolutionnary dPCR system

Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies Gallery

Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies

Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification Gallery

Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification

Stilla Technologies completes €16 Million ($18 Million) Series A

Stilla’s webinar in collaboration with Genomeweb and University Hospital of Dijon on Tuesday 25th of September 2018

Stilla’s webinar in collaboration with Nature and ICR London on Tuesday 12th of June 2018